Related Experiment Video
Updated: Jan 4, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Biomarker-Guided Tailored Therapy
Jessica Lydiard1, Charles B Nemeroff2,3
1Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, 33133, USA.
Personalized medicine in psychiatry shows promise for improving patient outcomes by integrating genetic and biomarker data. Further research is needed to determine the clinical utility of these advanced diagnostic and treatment approaches.
Area of Science:
- Psychiatry
- Personalized Medicine
- Biomarker Research
Background:
- Personalized medicine integrates genetic, epigenetic, biomarker, clinical, and environmental data.
- Psychiatric applications of personalized medicine are emerging with significant potential.
- Biomarker associations with treatment response in psychiatric disorders are increasingly documented.
Purpose of the Study:
- To explore the underdeveloped field of personalized medicine in psychiatry.
- To highlight the potential of integrating diverse data for improved psychiatric care.
- To review the current state of biomarker research in psychiatric disorders.
Main Methods:
- Review of studies investigating biomarkers (neuroimaging, electrophysiology, serum, genomics, epigenetics, proteomics, metabolomics) and clinical response.
- Analysis of integrated approaches combining biological, clinical, and environmental data.
- Assessment of progress in developing valid biomarkers for psychiatric disorders.
Main Results:
- Promising associations found between various biomarkers and psychopharmacological treatment response.
- Biomarkers include neuroimaging, electrophysiology, peripheral markers, and omics data.
- Integrated methodologies combining multiple data sources are considered optimal for complex psychiatric illnesses.
Conclusions:
- Personalized medicine holds profound potential for enhancing psychiatric prevention and treatment.
- Significant progress has been made in identifying psychiatric biomarkers.
- Further work is essential to establish the clinical utility of these biomarkers in psychiatric practice.
More Related Videos
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy
Therapeutic Drug Monitoring: Overview and Classification